S-100B and FDG-PET/CT in therapy response assessment of melanoma patients.

Strobel, Klaus; Skalsky, Jeannine; Steinert, Hans C; Dummer, Reinhard; Hany, Thomas F; Bhure, Ujwal; Seifert, Burkhardt; Pérez Lago, Marisol; Joller-Jemelka, Helen; Kalff, V

Strobel, Klaus; Skalsky, Jeannine; Steinert, Hans C; Dummer, Reinhard; Hany, Thomas F; Bhure, Ujwal; Seifert, Burkhardt; Pérez Lago, Marisol; Joller-Jemelka, Helen; Kalff, V.

Affiliation

Strobel K; Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland. klaus.strobel@usz.ch

Dermatology ; 215(3): 192-201, 2007.

Article in En | MEDLINE | ID: mdl-17823514

Subject(s)

Biomarkers, Tumor/blood; Melanoma/diagnosis; Nerve Growth Factors/blood; Positron-Emission Tomography; S100 Proteins/blood; Skin Neoplasms/diagnosis; Tomography, X-Ray Computed; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma/blood; Melanoma/diagnostic imaging; Middle Aged; Radiopharmaceuticals; S100 Calcium Binding Protein beta Subunit; Skin Neoplasms/blood; Skin Neoplasms/diagnostic imaging

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / S100 Proteins / Biomarkers, Tumor / Tomography, X-Ray Computed / Positron-Emission Tomography / Melanoma / Nerve Growth Factors Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Dermatology Journal subject: DERMATOLOGIA Year: 2007 Document type: Article Affiliation country: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links